Keyphrases
Additional Resection
5%
Adult-onset
12%
Age at Diagnosis
6%
Age Groups
6%
Age of Onset
12%
Age-dependent
56%
AIMS™
11%
Biologic Therapy
11%
Bowel Segment
5%
Confidence Interval
61%
Crohn's Disease
100%
Danish Population
5%
Disease Activity
16%
Disease Behavior
5%
Disease Localization
5%
Disease Location
5%
Disease-modifying Therapy
11%
Elderly Onset
43%
Frailty
12%
Group-based
6%
Hazard Ratio
61%
Health Registries
6%
Immunomodulator
12%
Inflammatory Bowel Disease
56%
Kaplan-Meier Plot
6%
Medical Treatment
5%
Multivariate Cox Regression Analysis
6%
National Cohort Study
56%
Patient Data
56%
Pediatric Onset
24%
Population-based Study
56%
Primary Resection
11%
Protective Effect
5%
Re-resection
56%
Recurrence Rate
5%
Recurrence Risk
5%
Recurrent Disease
56%
Resection
11%
Resection Rate
56%
Risk Factors
11%
Second Course
12%
Second Resection
5%
Stenotic Lesion
5%
Steroid-sparing
56%
Stoma Reversal
11%
Systemic Steroids
24%
Treatment Challenges
6%
Treatment Patterns
6%
Ulcerative Colitis
31%
Ulcerative Colitis Patient
12%
Nursing and Health Professions
Cohort Analysis
56%
Confidence Interval
56%
Crohn's Disease
43%
Drug Therapy
56%
Frailty
12%
Hazard Ratio
56%
Immunomodulating Agent
12%
Inflammatory Bowel Disease
56%
Onset Age
12%
Proportional Hazards Model
6%
Ulcerative Colitis
43%
Vascular Guide Wire
6%
Medicine and Dentistry
Cohort Analysis
56%
Crohn's Disease
43%
Drug Therapy
56%
Frailty
12%
Hazard Ratio
56%
Immunomodulating Agent
12%
Inflammatory Bowel Disease
56%
Onset Age
12%
Pediatrics
24%
Proportional Hazards Model
6%
Stoma
6%
Ulcerative Colitis
43%